News
Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...
Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...
School districts across Minnesota are struggling to contain double-digit health insurance cost increases. Some officials say ...
Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...
According to a new report from Big Chalk Analytics, GLP-1 users have cut $6.5 billion from U.S. grocery spend.
Ozempic, which is prescribed for diabetes, and Wegovy, prescribed for weight loss, both contain the active ingredient ...
Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?
In what Science magazine has dubbed “Novo Nordisk’s Canadian Mistake,” Ozempic is soon to come off patent in Canada, opening ...
The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.
Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...
A little weight gain during the menopause is normal, but when it happens to a generation who came of age in the skinny-chic ...
The weight loss and diabetes drug, which is only available on prescription, should be on pharmacy shelves within days ending ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results